Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is VIGABATRIN USP, with a corresponding US DMF Number 33769.
Remarkably, this DMF maintains an Active status since its submission on April 08, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 17, 2019, and payment made on April 08, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II